Based on these findings, investigating the role of these interactions among P4HB, PDIA4 and PDIA6 in driving aggressive tumor phenotypes, such as proliferation, invasion and metastasis, could uncover potential targets for anti-metastatic therapies. The gene discussed is PDIA6; the disease is neoplasm.